Susquehanna International Group
CURE icon

Susquehanna International Group’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Susquehanna International Group’s Portfolio CURE Stock Details CURE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.15M Buy
67,200
+32,400
+93% +$3.52M ﹤0.01% 3882
2025
Q4 		$3.88M Sell
34,800
-214,000
-86% -$21.9M ﹤0.01% 4446
2025
Q3 		$20.8M Buy
248,800
+217,500
+695% +$16.9M ﹤0.01% 2166
2025
Q2 		$2.47M Buy
31,300
+13,300
+74% +$1.07M ﹤0.01% 5354
2025
Q1 		$1.92M Buy
18,000
+1,700
+10% +$181K ﹤0.01% 5629
2024
Q4 		$1.5M Buy
16,300
+2,900
+22% +$327K ﹤0.01% 5952
2024
Q3 		$1.78M Sell
13,400
-9,200
-41% -$1.18M ﹤0.01% 5509
2024
Q2 		$2.64M Sell
22,600
-200
-0.9% -$22.5K ﹤0.01% 4551
2024
Q1 		$2.86M Sell
22,800
-2,900
-11% -$337K ﹤0.01% 4610
2023
Q4 		$2.61M Sell
25,700
-12,000
-32% -$1.08M ﹤0.01% 4815
2023
Q3 		$3.34M Sell
37,700
-9,500
-20% -$934K ﹤0.01% 4197
2023
Q2 		$4.72M Sell
47,200
-11,800
-20% -$1.17M ﹤0.01% 3641
2023
Q1 		$5.66M Buy
59,000
+23,700
+67% +$2.38M ﹤0.01% 3273
2022
Q4 		$4.05M Buy
35,300
+16,600
+89% +$1.8M ﹤0.01% 3562
2022
Q3 		$1.58M Buy
18,700
+1,800
+11% +$186K ﹤0.01% 5476
2022
Q2 		$1.74M Sell
16,900
-7,800
-32% -$879K ﹤0.01% 5209
2022
Q1 		$3.22M Sell
24,700
-16,000
-39% -$1.9M ﹤0.01% 4488
2021
Q4 		$5.9M Sell
40,700
-7,800
-16% -$947K ﹤0.01% 3480
2021
Q3 		$5.21M Buy
48,500
+29,500
+155% +$3.55M ﹤0.01% 3873
2021
Q2 		$1.99M Buy
19,000
+2,500
+15% +$240K ﹤0.01% 5925
2021
Q1 		$1.38M Sell
16,500
-9,200
-36% -$742K ﹤0.01% 6884
2020
Q4 		$1.98M Buy
25,700
+2,100
+9% +$145K ﹤0.01% 5120
2020
Q3 		$1.49M Buy
23,600
+1,900
+9% +$119K ﹤0.01% 5197
2020
Q2 		$1.18M Sell
21,700
-10,700
-33% -$568K ﹤0.01% 5546
2020
Q1 		$1.29M Buy
32,400
+5,400
+20% +$340K ﹤0.01% 4794
2019
Q4 		$1.99M Buy
27,000
+6,400
+31% +$391K ﹤0.01% 4345
2019
Q3 		$1.04M Buy
20,600
+300
+1% +$15.9K ﹤0.01% 5595
2019
Q2 		$1.14M Sell
20,300
-22,700
-53% -$1.17M ﹤0.01% 5355
2019
Q1 		$2.39M Sell
43,000
-5,200
-11% -$277K ﹤0.01% 3477
2018
Q4 		$2.29M Sell
48,200
-26,000
-35% -$1.46M ﹤0.01% 3321
2018
Q3 		$4.94M Buy
74,200
+21,100
+40% +$1.21M ﹤0.01% 2716
2018
Q2 		$2.41M Buy
53,100
+4,100
+8% +$183K ﹤0.01% 3715
2018
Q1 		$2.11M Buy
49,000
+21,200
+76% +$1.07M ﹤0.01% 3816
2017
Q4 		$1.29M Buy
27,800
+1,400
+5% +$64.9K ﹤0.01% 4718
2017
Q3 		$1.2M Buy
26,400
+8,100
+44% +$349K ﹤0.01% 4935
2017
Q2 		$763K Sell
18,300
-3,500
-16% -$130K ﹤0.01% 5833
2017
Q1 		$751K Sell
21,800
-100
-0.5% -$3.25K ﹤0.01% 5737
2016
Q4 		$604K Sell
21,900
-1,500
-6% -$42.3K ﹤0.01% 6588
2016
Q3 		$746K Sell
23,400
-16,300
-41% -$554K ﹤0.01% 5347
2016
Q2 		$1.26M Buy
39,700
+28,000
+239% +$844K ﹤0.01% 4394
2016
Q1 		$318K Sell
11,700
-20,400
-64% -$537K ﹤0.01% 7166
2015
Q4 		$1.07M Sell
32,100
-49,100
-60% -$1.55M ﹤0.01% 5266
2015
Q3 		$2.15M Sell
81,200
-12,800
-14% -$470K ﹤0.01% 4140
2015
Q2 		$3.7M Sell
94,000
-4,000
-4% -$138K ﹤0.01% 3469
2015
Q1 		$2.88M Buy
98,000
+500
+0.5% +$14K ﹤0.01% 3633
2014
Q4 		$2.43M Sell
97,500
-20,500
-17% -$482K ﹤0.01% 4082
2014
Q3 		$2.44M Buy
118,000
+24,500
+26% +$476K ﹤0.01% 4257
2014
Q2 		$1.68M Buy
+93,500
New +$1.51M ﹤0.01% 4998

Other funds holding CURE

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
OBWG
Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $968M AUM 19.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Susquehanna International Group's CURE Position: Q1 2026 in Review

Susquehanna International Group reduced its Direxion Daily Healthcare Bull 3X ETF (CURE) stake by 46% in Q1 2026, selling an estimated $1.32M and leaving 14,032 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #7257.

Susquehanna International Group first reported a position in CURE in Q2 2013 and has held it in 46 quarters since. The position peaked at $6.48M in Q1 2023. 15 funds tracked by Wall St. Rank hold CURE as of Q1 2026.

  • Susquehanna International Group held 14,032 shares of Direxion Daily Healthcare Bull 3X ETF worth $1.28M as of Q1 2026.
  • Susquehanna International Group sold 12,186 Direxion Daily Healthcare Bull 3X ETF shares in Q1 2026, an estimated $1.32M.
  • Direxion Daily Healthcare Bull 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7257 holding.
  • Susquehanna International Group first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2013 and has held it in 46 quarters since.
  • Susquehanna International Group's Direxion Daily Healthcare Bull 3X ETF position peaked at $6.48M in Q1 2023.
  • 15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.